Leishmaniases are a group of tropical diseases caused by a number of species of protozoan parasites belonging to the genus Leishmania that survive and multiply in macrophages in the mammalian host and are transmitted by female flying insects of genera Phleobotomus and Lutzomyia. Currently, 12 million people in developing countries are affected by the disease annually. 1, 2) In many cases, the medicines employed for treatment are toxic, only slightly effective, given by injection, and compromised by the development of resistance. 3) Since safe, effective, and affordable drugs for leishmaniases are needed in developing countries, there have been many studies on leishmanicidal constituents from plant sources, [4] [5] [6] but there are as yet no safe, effective, and reasonably priced drugs. In our project, sesquiterpene lactone 7) and steroid saponines 8) were isolated as leishmanicidal constituents. We have been testing tropical medicinal plants for developing lead compounds for leishmanicidal medicines. Of these testing samples, the Nepalese traditional crude drug, Tulsi (Ocimum sanctum L.), was identified as a potent leishmanicidal sample. Seven new neolignan derivatives were isolated from the sources, derived by polymerization of eugenol. This paper deals with the isolation and structural elucidation of new novel neolignan derivatives and the leishmanicidal activity of compounds isolated from O. sanctum L.
Results and Discussion
Methanol (MeOH) extract of O. sanctum L. was partitioned with ethylacetate (AcOEt) and n-buthanol (n-BuOH) to give AcOEt, n-BuOH, and aqueous fractions. Active AcOEt fraction was separated by successive chromatographies, as described in the Experimental section, to give seven new compounds (1-7) and 16 known compounds (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (Fig. 1 ). The structures of the known compounds were determined by data from MS and NMR spectra as follows:
eugenol (8) , citrusin C (9), 9) ferulaldehyde (10), bieugenol (11), 10) dehydrodieugenol B (12), 11) oleanolic acid (13) , ulsoric acid (14) , stigmasterol (15) , 12) b-sitosterol-3-O-b-Dglucopyranoside (16) , caryophyllene oxide (17), 13) apigenin (18) , 14) luteolin (19) , 15) crysoeriol (20) , 16) 4Ј,5-dihydroxy-7,8-dimethoxyflavone (21), 17) 4Ј,5-dihydroxy-3Ј,7,8-trimethoxyflavone (22), 18) and vanillin (23 (Table 2 ). This indicated that 1 has a flavan-3-ol skeleton having two methoxy groups, an allyl group, and a hydroxyl group. The positions of functional groups were determined by heteronuclear multiple bond connectivity (HMBC) experiments of 1, as shown in Fig. 2 These data indicated that 1 was 6-allyl-3Ј,8-dimethoxy-flavan-3,4Ј-diol, and the compound was named tulsinol A. The relative configuration between C-7Ј and 8Ј resulted in trans from the coupling constant of H-7Ј with H-8Ј (Jϭ7.8 Hz). 19) The absolute configuration of 1 was not studied because of low optical rotation ([a] D ϩ1.5°) and no Cotton effect in circular dichroism (CD) spectrum of 1.
Compound 2 was obtained as a pale yellow viscous oil. HR-ESI-MS of 2 showed a pseudomolecular ion at m/z 511.2113 [MϩNa] ϩ C 30 H 32 O 6 Na, which accorded to the molecular formula C 30 H 32 O 6 . The IR spectrum of 2 showed absorptions at 3444, 2935, 1594, and 1269 cm
Ϫ1
. The UV spectrum of 2 showed absorption at 234 (e 13300) and 279 (e 6100) nm. The The relative configuration at C-7Ј and 8Ј was determined to be trans from the coupling constant (Jϭ6.4 Hz) between H-7Ј and H-8Ј. Optical rotation of 2 gave a low value ([a] D ϩ1.5°) and the CD spectrum of 2 showed no Cotton effect, indicating the possibility of low optical purity in 2; therefore, the absolute configuration of 2 was not studied. The structure was determined to be 6-allyl-3-(4-allyl-2-methoxyphenoxy)-3Ј,8-dimethoxyflavan-4Ј-ol, and the compound was named tulsinol B.
Compound C-NMR spectrum of 3 showed 30 carbon signals, which showed that 3 was a trimer of eugenol. The Fig.  2 . These data showed that 3 has a dihydrobenzfurane skeleton. Thus the structure of 3 was determined to be 5-allyl-3-(4-allyl-2-methoxyphenoxymethyl)-2-(4-hydroxy-3-methoxyphenyl)-7-methoxy-2,3-dihydrobenzofuran. Stereochemistry at C-7Ј and 8Ј was determined as trans from observation of the NOE between H-7Ј and CH 2 -9Ј, and the compound was named tulsinol C. . These data showed the replacement of the methyl group in 4 to the eugenol moiety in 5. The 13 C-NMR data (in Table 2 ) also supported the structure of 5, in which one more eugenol moiety was substituted at C-7. The structure of 5 was confirmed by the HMBC spectrum 150.8, 151.1, 153.2) . These data indicate that 6 is an eugenol trimer. The three eugenol units of 6 were confirmed as two 1,2-dioxy-3-methoxy-5-allylbenzene and a 1-methoxy-2-oxy-5-allylbenzene structures from HMBC experiments, as shown in Fig. 2 . Compound 6 should be derived by the phenol oxidation reaction between C-5 and oxygen at C-4 of eugenol. Thus, the structure of 6 was inevitably determined to be 1-allyl-4-(5-allyl-2-hydroxy-3-methoxyphenoxy)-3-(4-allyl-2-methoxyphnoxy)-5-methoxybenzene, and the compound was named tulsinol F. Fig. 2 . In the rotating frame nuclear Overhauser effect spectroscopy (ROESY) experiment, H-7Ј showed a correlation with H-9Ј. Thus the C-7Ј,8Ј double bond was an E configuration, but the coupling constant (Jϭ12.0 Hz) between H-7Ј and H-8Ј was small for ordinal E configuration. This could be explained from substitution of the electro-negative atom oxygen at C-7Ј. From these data, the structure of 7 was determined to be 3-(5-allyl-2-hydroxy-3-methoxyphenyl)-1-(4-hydroxy-3-methoxyphenoxy)-propene, and the compound was named tulsinol G.
Compounds 1 and 2 have very interesting structures. They should be synthesized from eugenol through oligomerization, thus they belong to the neolignan group in biosynthetic standpoint, but they have a flavan-3-ol skeleton and belong to the flavone group in structural standpoint.
Some isolated compounds were tested for leishmanicidal activity against promastigotes of Leishmania major and the results are shown in Table 3 . Known compounds, ferulaldehyde and ulsoric acid, showed strong leishmanicidal activity (IC 50 0.9 and 2.2 mg/ml, respectively). Of the new compounds, 3 showed strong activity (IC 50 9.1 mg/ml). Eugenol dimers 11 and 12 also showed activity (IC 50 13.6 and 16.9 mg/ml, respectively). Some of the new compounds showed medium activity, as shown in Table 3 .
Experimental
UV and IR spectra were obtained by U-2001 (Hitachi) and FT-IR spectroscopy (Perkin Elmer). Optical rotations were measured by JASCO P-1010 polarimeter at room temperature. NMR spectra were recorded on a Unity INOVA 500 spectrometer (Varian Inc., Palo Alto, CA, U.S.A.). HR-ESI-TOF-MS spectra were obtained on a Micromass Q-Tof micro mass spectrometer (Waters Corp., Milford, MA, U.S.A.). Preparative and analytical HPLC was carried out on reverse-phase columns (Mighty sil RP-18 and 8, Kantho Chemical Co., Ltd.) with the CH 3 CN-H 2 O solvent system. Silica gel 60N (Kantho Chemical Co., Ltd.) was used for column chromatography. Analytical and preparative TLC were carried out on precoated Kieselgel 60F 254 (Merck) and spots were visualized by spraying the plates with 50% H 2 SO 4 solution, followed by heating.
Plant Material The crude drug, Tulsi, was purchased at a market in Kathmandu, Nepal, in August 2003. The botanical identification was made by Dr. A. Takano of Showa Pharmaceutical University. A voucher specimen is deposited in the laboratory of Natural Product Chemistry of the Faculty of Life and Environmental Sciences, Prefectural University of Hiroshima, Shobara, Hiroshima, Japan.
Isolation of Constituents Dried leaves of Tulsi (Ocimum sanctum L.) (1 kg) were extracted with methanol (MeOH) under reflux to give MeOH extract (106 g). The MeOH extract was partitioned between ethyl acetate (AcOEt) and water to give an AcOEt layer and aqueous layer. The aqueous layer was partitioned with n-butanol (n-BuOH) to give a n-BuOH layer. The AcOEt layer and n-BuOH layer were evaporated to give AcOEt extract (37.4 g) and n-BuOH extract (20.3 g). Both extracts showed leishmanicidal activity, but the AcOEt extract showed many constituents on TLC analysis. Thus the AcOEt extract was chromatographed on a silica gel column using a gradient chloroform (CHCl 3 )-MeOH solvent system to give 11 fractions, Fr. 1-Fr. 11. Fr. 2 (6.19 g) was purified by successive column chromatography and HPLC using an ODS column to give compounds 8 (1.8 g), 10 (3 mg), 12 (118 mg) and 17 (43 mg). Fr. 3 (4.96 g) was also purified by similar procedure to give compounds 2 (51 mg), 3 (7 mg), 5 (3 mg), 6 (5 mg), and 7 (5 mg); Fr. 4 (1.62 g) gave compounds 11 (71 mg), 15 (69 mg), and 23 (47 mg); Fr. 5 (2.93 g) gave compounds 4 (6 mg) and 10 (21 mg); Fr. 6 (4.05 g) gave compounds 1 (16 mg) and 22 (42 mg); Fr. 7 (2.93 g) gave compound, 13 (173 mg) and 14 (262 mg); Fr. 8 (2.82 g) gave compound 21 (15 mg); Fr. 9 (4.27 g) gave compounds 18 (72 mg) and 20 (9 mg); and Fr. 10 (1.98 g) gave compounds 9 (10 mg), 16 (104 mg), and 19 (19 mg Table 1 and   13 C-NMR is shown in Table 2 .
Leishmanicidal Activity Test The leishmanicidal activities of isolated compounds were tested by an improved MTT method as follows. Basically, the reported method 20) was employed except that Tetra Color One {the mixture of WST-8 [2-(2-methoxy-4-nitrophenyl)-3-(4-disulfophenyl)-2H-tetrazorium, monosodium salt] and 1-methoxy PMS (1-methoxy-5-methylphenazinium methosukfate) (SeikagakuKogyou Co., Ltd.)} were used instead of MTT. Cultured promastigotes were centrifuged at 600 g at 4°C for 5 min. The parasites were resuspended in each culture and diluted to a density of 1ϫ10 5 /ml. L. major promastigotes were seeded at 0.5ϫ10 4 / 50 ml in medium/well in a 96-well microplate, and then a further 50 ml medium/well with different concentrations of test compounds dissolved in dimethyl sulfoxide (DMSO) were added to each well. Each concentration was tested in triplicate. As positive controls, amphotericin B and pentamidine were investigated. The microplate was incubated at 27°C in 5% CO 2 for 72 h. Tetra Color One was added to each well and the plates were incubated at 27°C for 6 h. Optical density at 630 nm was measured using a microplate reader (Molecular Devices Co., Ltd.). Leishmanicidal activity was expressed as the 50% inhibitory concentration (IC 50 ). Vol. 57, No. 3 
